Influenza Vaccination: The Right Vaccine for the Right Person

This case series has been developed with the assistance of Dr. Donald Middleton (UPMC St. Margaret, Pittsburgh, PA, USA). This program was supported by CSL Seqirus.

The information presented is not intended as medical advice. Responsibility for patient care resides with the healthcare professional (HCP) on the basis of their professional license, experience, and knowledge of the individual patient.

For full prescribing information, including indications, contraindications, warnings, precautions, and adverse events, please refer to the approved product labeling. Please note that products may have different product labeling according to geographical location. For instance, in the United States, full prescribing information is available from the US Food and Drug Administration (fda.gov).

AFLURIA® QUADRIVALENT, FLUAD® QUADRIVALENT, FLUCELVAX® QUADRIVALENT and MF59® are trademarks of Seqirus UK Limited or its affiliates. All other trademarks referenced herein are property of their respective owners.

All characters and events depicted in this patient case simulation are entirely fictitious. Any similarity to actual events or persons, living or dead, is purely coincidental. This activity is intended for HCPs practicing in the USA but may be accessed by HCPs practicing globally. To proceed, please confirm that you are an HCP.

Modules

  • A 72-year-old man with multiple comorbidities

  • A healthy 1-year-old girl at a routine check-up

Previous
Previous

Improving patient outcomes in allogeneic HSCT through treosulfan-based conditioning therapy

Next
Next

CAR T-Cell Therapy in Lymphoma: Current Practices and New Perspectives